<http://schema.org/description>
"Nuvigil failed to meet the primary endpoint in a phase III study for bipolar I disorder."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/91198/disappointing-data-from-teva>